Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

ClinicalTrials.gov ID: NCT00003411

Public ClinicalTrials.gov record NCT00003411. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Dose Escalation and Pharmacokinetics Study of the Radiosensitizer, Gadolinium Texaphyrin (Gd-Tex, NSC 695238) With Concurrent Radiotherapy in Advanced Biliary Tree and Pancreatic Cancers

Study identification

NCT ID: NCT00003411
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: University of Pittsburgh; Other
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

motexafin gadolinium Drug
radiation therapy Radiation

Drug · Radiation

Eligibility (public fields only)

Age range: 18 Years to 120 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 1998
Primary completion: May 31, 2002
Completion: May 31, 2002
Last update posted: Jan 17, 2016

1998 – 2002

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
Norris Cotton Cancer Center	Lebanon	New Hampshire	03756-0002	—
University of Pittsburgh Cancer Institute	Pittsburgh	Pennsylvania	15213-3489	—
University of Wisconsin Comprehensive Cancer Center	Madison	Wisconsin	53792-6164	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00003411, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 17, 2016 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003411 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →